Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryan L Davis

Showing results (41-50 of 61) with videos related to

Pageof 7
Sort By:
Frontiers in Aging Neuroscience|June 3, 2022
The Gut Microbiome in Parkinson's Disease: A Longitudinal Study of the Impacts on Disease Progression and the Use of Device-Assisted TherapiesMichal Lubomski, Xiangnan Xu, Andrew J Holmes, et al.
International Journal of Cardiology|December 26, 2014
Systematic review of cardiac electrical disease in Kearns-Sayre syndrome and mitochondrial cytopathyPeter Kabunga, Antony K Lau, Kevin Phan, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 8, 2020
Citrulline Not a Major Determinant in the Recognition of Peptidylarginine Deiminase 2 and 4 by Autoantibodies in Rheumatoid ArthritisErika Darrah, Ryan L Davis, Ashley M Curran, et al.
American Journal of Medical Genetics. Part A|April 8, 2022
Decompensation of cardiorespiratory function and emergence of anemia during pregnancy in a case of mitochondrial myopathy, lactic acidosis, and sideroblastic anemia 2 with compound heterozygous YARS2 pathogenic variantsLaura I Rudaks, Eloise Watson, Carly Oboudiyat, et al.
Arthritis Research & Therapy|June 7, 2021
Anti-peptidylarginine deiminase-4 antibodies at mucosal sites can activate peptidylarginine deiminase-4 enzyme activity in rheumatoid arthritisM Kristen Demoruelle, Hong Wang, Ryan L Davis, et al.
Frontiers in Immunology|December 6, 2018
Autoantibodies to Peptidylarginine Deiminase 2 Are Associated With Less Severe Disease in Rheumatoid ArthritisErika Darrah, Jon T Giles, Ryan L Davis, et al.
Molecular Neurobiology|January 7, 2022
Strong Predictive Algorithm of Pathogenesis-Based Biomarkers Improves Parkinson's Disease DiagnosisDaniel Kam Yin Chan, Nady Braidy, Ren Fen Chen, et al.
Stem Cell Research|August 1, 2025
PARKIN protein-deficient iPSC line (FINi006-A) from an early-onset Parkinson's disease female patientChiara Pavan, Jennifer Jin, Sharon Jong, et al.
Molecular Genetics and Metabolism Reports|August 11, 2018
Expanding the spectrum of <i>PEX16</i> mutations and novel insights into disease mechanismsKishore R Kumar, Gautam Wali, Ryan L Davis, et al.
Cerebellum (London, England)|May 20, 2019
Increased Diagnostic Yield of Spastic Paraplegia with or Without Cerebellar Ataxia Through Whole-Genome SequencingAryun Kim, Kishore R Kumar, Ryan L Davis, et al.
Pageof 7

Showing results (41-50 of 61) with videos related to

Sort By:
Pageof 7
Frontiers in Aging Neuroscience|June 3, 2022
The Gut Microbiome in Parkinson's Disease: A Longitudinal Study of the Impacts on Disease Progression and the Use of Device-Assisted TherapiesMichal Lubomski, Xiangnan Xu, Andrew J Holmes, et al.
International Journal of Cardiology|December 26, 2014
Systematic review of cardiac electrical disease in Kearns-Sayre syndrome and mitochondrial cytopathyPeter Kabunga, Antony K Lau, Kevin Phan, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 8, 2020
Citrulline Not a Major Determinant in the Recognition of Peptidylarginine Deiminase 2 and 4 by Autoantibodies in Rheumatoid ArthritisErika Darrah, Ryan L Davis, Ashley M Curran, et al.
American Journal of Medical Genetics. Part A|April 8, 2022
Decompensation of cardiorespiratory function and emergence of anemia during pregnancy in a case of mitochondrial myopathy, lactic acidosis, and sideroblastic anemia 2 with compound heterozygous YARS2 pathogenic variantsLaura I Rudaks, Eloise Watson, Carly Oboudiyat, et al.
Arthritis Research & Therapy|June 7, 2021
Anti-peptidylarginine deiminase-4 antibodies at mucosal sites can activate peptidylarginine deiminase-4 enzyme activity in rheumatoid arthritisM Kristen Demoruelle, Hong Wang, Ryan L Davis, et al.
Frontiers in Immunology|December 6, 2018
Autoantibodies to Peptidylarginine Deiminase 2 Are Associated With Less Severe Disease in Rheumatoid ArthritisErika Darrah, Jon T Giles, Ryan L Davis, et al.
Molecular Neurobiology|January 7, 2022
Strong Predictive Algorithm of Pathogenesis-Based Biomarkers Improves Parkinson's Disease DiagnosisDaniel Kam Yin Chan, Nady Braidy, Ren Fen Chen, et al.
Stem Cell Research|August 1, 2025
PARKIN protein-deficient iPSC line (FINi006-A) from an early-onset Parkinson's disease female patientChiara Pavan, Jennifer Jin, Sharon Jong, et al.
Molecular Genetics and Metabolism Reports|August 11, 2018
Expanding the spectrum of <i>PEX16</i> mutations and novel insights into disease mechanismsKishore R Kumar, Gautam Wali, Ryan L Davis, et al.
Cerebellum (London, England)|May 20, 2019
Increased Diagnostic Yield of Spastic Paraplegia with or Without Cerebellar Ataxia Through Whole-Genome SequencingAryun Kim, Kishore R Kumar, Ryan L Davis, et al.
Pageof 7